Institutional investors purchased a net $8.0 million shares of AMGN during the quarter ended December 2016 and now own 80.56% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.0 Million shares of Amgen
UBS ASSET MANAGEMENT (AMERICAS) ... Bought 2.3 Million shares of Amgen
BLACKROCK FUND ADVISORS Bought 2.1 Million shares of Amgen